Literature DB >> 31353204

Serum lipid profile as a biomarker of intra-pancreatic fat deposition: A nested cross-sectional study.

Ruma G Singh1, Ngoc N Nguyen1, Aya Cervantes1, Jaelim Cho1, Maxim S Petrov2.   

Abstract

BACKGROUND AND AIMS: The relationship between intra-pancreatic fat deposition (IPFD) and lipid profile has been investigated in individuals with obesity and/or type 2 diabetes, but not in healthy non-obese individuals and those after acute pancreatitis. The aim of the study was to investigate the association between serum lipid profile and IPFD in the latter individuals and to determine the effect of abdominal fat distribution and other covariates. METHODS AND
RESULTS: A total of 90 individuals with a history of acute pancreatitis as well as 23 healthy non-obese individuals participated in the study. Magnetic resonance imaging was used to quantify IPFD and visceral-to-subcutaneous fat volume ratio, followed by fasting state measurement of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), TC/HDL-C ratio, and triglycerides. In healthy non-obese individuals, IPFD was not significantly associated with any of the studied markers. In individuals after acute pancreatitis, IPFD was significantly associated with triglycerides in both unadjusted (β = 0.360; 95% CI, 0.090-0.629; p = 0.009) and adjusted models, with a β-coefficient of 0.280 [(95% CI, 0.016-0.545); p = 0.038] in the most adjusted model. Also, IPFD was significantly associated with TC/HDL-C ratio in both unadjusted (β = 0.336; 95% CI, 0.045-0.626; p = 0.024) and adjusted models, with a β-coefficient of 0.375 [(95% CI, 0.090-0.660); p = 0.010] in the most adjusted model. Multiple regression yielded triglycerides, but not TC/HDL-C ratio, as a significant marker of IPFD in individuals after acute pancreatitis.
CONCLUSIONS: Serum lipid profile is not associated with IPFD in healthy non-obese. Triglycerides, but not other components of lipid profile, is a promising biomarker for IPFD in individuals following acute pancreatitis.
Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Biomarkers; Fat distribution; Intra-pancreatic fat deposition; Lipid profile

Mesh:

Substances:

Year:  2019        PMID: 31353204     DOI: 10.1016/j.numecd.2019.06.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  7 in total

Review 1.  Intra-pancreatic fat deposition: bringing hidden fat to the fore.

Authors:  Maxim S Petrov; Roy Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-08       Impact factor: 46.802

2.  Chronic Pancreatitis Is Characterized by Elevated Circulating Periostin Levels Related to Intra-Pancreatic Fat Deposition.

Authors:  Juyeon Ko; Charlotte E Stuart; Andre E Modesto; Jaelim Cho; Sakina H Bharmal; Maxim S Petrov
Journal:  J Clin Med Res       Date:  2020-08-15

3.  Psoas muscle size as a magnetic resonance imaging biomarker of progression of pancreatitis.

Authors:  Andre E Modesto; Charlotte E Stuart; Jaelim Cho; Juyeon Ko; Ruma G Singh; Maxim S Petrov
Journal:  Eur Radiol       Date:  2020-02-10       Impact factor: 5.315

4.  Associations Between Cannabis Use, Abdominal Fat Phenotypes and Insulin Traits.

Authors:  Charlotte E Stuart; Juyeon Ko; Gisselle C Alarcon Ramos; Andre E Modesto; Jaelim Cho; Maxim S Petrov
Journal:  J Clin Med Res       Date:  2020-06-04

5.  The Relationship between Abdominal Fat Phenotypes and Insulin Resistance in Non-Obese Individuals after Acute Pancreatitis.

Authors:  Juyeon Ko; Loren Skudder-Hill; Jaelim Cho; Sakina H Bharmal; Maxim S Petrov
Journal:  Nutrients       Date:  2020-09-21       Impact factor: 5.717

Review 6.  Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.

Authors:  Ming-Ling Chang
Journal:  Biomedicines       Date:  2022-03-17

7.  Oxyntomodulin May Distinguish New-Onset Diabetes After Acute Pancreatitis From Type 2 Diabetes.

Authors:  Sakina H Bharmal; Jaelim Cho; Charlotte E Stuart; Gisselle C Alarcon Ramos; Juyeon Ko; Maxim S Petrov
Journal:  Clin Transl Gastroenterol       Date:  2020-02       Impact factor: 4.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.